Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF – Get Free Report) was the target of a large drop in short interest in June. As of June 30th, there was short interest totaling 21,160 shares, a drop of 35.1% from the June 15th total of 32,585 shares. Based on an average daily trading volume, of 2 shares, the short-interest ratio is currently 10,580.0 days.
Towa Pharmaceutical Price Performance
OTCMKTS TWAPF opened at $26.00 on Friday. Towa Pharmaceutical has a 52 week low of $25.71 and a 52 week high of $26.00. The company has a fifty day moving average of $25.46 and a two-hundred day moving average of $25.37.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley upgraded shares of Towa Pharmaceutical to an “overweight” rating in a research report on Friday, June 12th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, Towa Pharmaceutical has an average rating of “Buy”.
Towa Pharmaceutical Company Profile
Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.
In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.
Featured Stories
- Five stocks we like better than Towa Pharmaceutical
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Towa Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Towa Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
